In vivo administration of granulocyte colony-stimulating factor increases the surface expression of sialyl-Lewis(x) on neutrophils in healthy volunteers

Acta Haematologica

Volumn 100, Issue 4, 1998, Pages 187-190

  Ohsaka, Akimichi ^a   Saionji, Katsu ^b  

^a Hitachi   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Granulocyte colony stimulating factor; Neutrophils; Selectin; sialyl Lewis(x)

Indexed keywords

CELL ADHESION MOLECULE; FC RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; L SELECTIN; LIGAND; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; CELL INTERACTION; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE COUNT; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANTIGENS, CD14; GANGLIOSIDES; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INJECTIONS, SUBCUTANEOUS; L-SELECTIN; LEUKOCYTE COUNT; LEWIS BLOOD-GROUP SYSTEM; MEMBRANE PROTEINS; NEUTROPHILS; RECEPTORS, IGG;

EID: 0032469505     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000040901     Document Type: Article

References (12)

1. Kansas GS: Selectins and their ligands: Current concepts and controversies. Blood 1996;88: 3259-3287.
2. Polley MJ, Phillips ML, Wayner E, Nudelman E, Singhal AK, Hakomori S-I, Paulson JC: CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. Proc Natl Acad Sci USA 1991;88:6224-6228.
3. Ohsaka A, Saionji K, Sato N, Mori T, Ishimoto K, Inamatsu T: Granulocyte colony-stimulating factor down-regulates the surface expression of the human leucocyte adhesion molecule-1 on human neutrophils in vitro and in vivo. Br J Haematol 1993;84:574-580.
4. Ohsaka A, Saionji K, Kuwaki T, Takeshima T, Igari J: Granulocyte colony-stimulating factor administration modulates the surface expression of effector cell molecules on human monocytes. Br J Haematol 1995;89:465-472.
5. Ohsaka A, Saionji K, Igari J: Granulocyte colony-stimulating factor administration increases serum concentrations of soluble selectins. Br J Haematol 1998;100:66-69.
6. Spiekermann K, Emmendoerffer A, Elsner J, Raeder E, Lohmann-Matthes M-L, Prahst A, Link H, Freund M, Welte K, Roesler J: Altered surface marker expression and function of G-CSF-induced neutrophils from test subjects and patients under chemotherapy. Br J Haematol 1994;87:31-38.
7. Varki A: Selectin ligands. Proc Natl Acad Sci USA 1994;91:7390-7397.
8. Alon R, Feizi T, Yuen C-T, Fuhlbrigge RC, Springer TA: Glycolipid ligands for selectins support leukocyte tethering and rolling under flow conditions. J Immunol 1995;154:5356-5366.
9. Etzioni A, Frydman M, Pollack S, Avidor I, Phillips ML, Paulson JC, Gershoni-Baruch R: Recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med 1992;327:1789-1792A.
10. Ley K, Zakrzewicz A, Hanski C, Stoolman LM, Kansas GS: Sialylated O-glycans and L-selectin sequentially mediate myeloid cell rolling in vivo. Blood 1995;85:3727-3735.
11. Moore KL, Stults NL, Diaz S, Smith DF, Cummings RD, Varki A, McEver RP: Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells. J Cell Biol 1992;118: 445-456.
12. Symington FW, Hedges DL, Hakomori S-I: Glycolipid antigens of human polymorphonuclear neutrophils and the inducible HL-60 myeloid leukemia line. J Immunol 1985;134: 2498-2506.